Cargando…
Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis
BACKGROUND: The numbers of confirmed cases of coronavirus disease 2019 (COVID-19) and COVID-19 related deaths are still increasing, so it is very important to determine the risk factors of COVID-19. Dyslipidemia is a common complication in patients with COVID-19, but the association of dyslipidemia...
Autores principales: | Liu, Yanli, Pan, Yilong, Yin, Yuyao, Chen, Wenhao, Li, Xiaodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314261/ https://www.ncbi.nlm.nih.gov/pubmed/34315474 http://dx.doi.org/10.1186/s12985-021-01604-1 |
Ejemplares similares
-
Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2020) -
Editorial: Dyslipidemia, obesity and coronavirus disease 2019 (COVID-19)
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2022) -
Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study
por: Yue, Jiang, et al.
Publicado: (2021) -
Obesity is associated with severe disease and mortality in patients with coronavirus disease 2019 (COVID-19): a meta-analysis
por: Cai, Zixin, et al.
Publicado: (2021) -
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
por: Lippi, Giuseppe, et al.
Publicado: (2020)